Billionaire-Backed San Diego Startup, Human Longevity, Gets $70 Million To Take On Aging

Published: Mar 07, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

J. Craig Venter, the human genome pioneer, today unveiled a new San Diego-based venture with an ambitious goal of providing whole genome sequencing and cell-therapy-based diagnostic services for patients. Venter said he co-founded the company, Human Longevity Inc., or HLI, with Robert Hariri, who oversaw Celgene Cellular Therapeutics and Peter Diamandis of the X Prize Foundation. The company already has raised $70 million in Series A venture financing that includes a Malaysian investment fund that also is the lead investor of another Venter venture, Synthetic Genomics, San Diego-based Illumina (NASDAQ: ILMN), and other individual investors.

Help employers find you! Check out all the jobs and post your resume.

Back to news